Catherine Llorens-Cortes receives the 2014 Galien France pharmaceutical research award for her work on the key role of angiotensin III at brain level in the control of blood pressure

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, is pleased to announce that Dr Catherine Llorens-Cortes has been given the Galien France award (research category), presented at the 45th edition of these prestigious international awards, which celebrate work in pharmaceutical research annually.

Download press release